James E Flynn Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Over the past year James E Flynn has been an insider in 10 companies. The total value of shares held by James E Flynn in these companies amounts to $12,414,862.

James E Flynn 10% Owner
Aclaris Therapeutics, Inc.
Director
Acutus Medical, Inc.
Director
AdaptHealth Corp.
10% Owner
Adverum Biotechnologies, Inc.
10% Owner
ALIMERA SCIENCES INC
Director, 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
Annexon, Inc.
10% Owner
ANTARES PHARMA, INC.
10% Owner
ARENA PHARMACEUTICALS INC
10% Owner
ARVINAS, INC.
10% Owner
aTYR PHARMA INC
10% Owner
Audentes Therapeutics, Inc.
10% Owner
Auspex Pharmaceuticals, Inc.
10% Owner
AVADEL PHARMACEUTICALS PLC
Director
AveXis, Inc.
10% Owner
Axogen, Inc.
10% Owner
Black Diamond Therapeutics, Inc.
10% Owner
Cabaletta Bio, Inc.
10% Owner
CAS MEDICAL SYSTEMS INC
10% Owner
CATALYST BIOSCIENCES, INC.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
Cyclacel Pharmaceuticals, Inc.
10% Owner
CytomX Therapeutics, Inc.
Director
Deerfield Healthcare Technology Acquisitions Corp.
Director
DFP HEALTHCARE ACQUISITIONS CORP.
10% Owner
Dicerna Pharmaceuticals Inc
10% Owner
DUSA PHARMACEUTICALS INC
10% Owner
DYNAVAX TECHNOLOGIES CORP
10% Owner
Edgewise Therapeutics, Inc.
10% Owner
Editas Medicine, Inc.
10% Owner
eHealth, Inc.
10% Owner
EMAGEON INC
10% Owner
Fibrocell Science, Inc.
10% Owner
Frequency Therapeutics, Inc.
10% Owner
Generation Bio Co.
10% Owner
HI TECH PHARMACAL CO INC
10% Owner, Director
Homology Medicines, Inc.
10% Owner
INSPIRE PHARMACEUTICALS INC
10% Owner
Invuity, Inc.
10% Owner
ISTA PHARMACEUTICALS INC
10% Owner
Kiniksa Pharmaceuticals, Ltd.
10% Owner
Larimar Therapeutics, Inc.
10% Owner
Loxo Oncology, Inc.
10% Owner
LUMOS PHARMA, INC.
10% Owner
Mallinckrodt plc
10% Owner
MEDICINES CO /DE
10% Owner
Mirum Pharmaceuticals, Inc.
10% Owner
Neos Therapeutics, Inc.
10% Owner
NeurogesX Inc
10% Owner
NeuroMetrix, Inc.
10% Owner
NITROMED INC
10% Owner
Nkarta, Inc.
10% Owner
NxStage Medical, Inc.
Director
Oncorus, Inc.
10% Owner
PAR PHARMACEUTICAL COMPANIES, INC.
Director
Protara Therapeutics, Inc.
10% Owner
Recro Pharma, Inc.
10% Owner
REGENXBIO Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
RIGEL PHARMACEUTICALS INC
10% Owner
Schrodinger, Inc.
10% Owner
Shockwave Medical, Inc.
10% Owner
SteadyMed Ltd.
10% Owner
STREAMLINE HEALTH SOLUTIONS INC.
10% Owner
Syros Pharmaceuticals, Inc.
Director
Talon Therapeutics, Inc.
10% Owner
Terns Pharmaceuticals, Inc.
10% Owner
THIRD WAVE TECHNOLOGIES INC /WI
10% Owner
TriVascular Technologies, Inc.
10% Owner
Vanda Pharmaceuticals Inc.
10% Owner
VIA Pharmaceuticals, Inc.
10% Owner
Werewolf Therapeutics, Inc.
10% Owner
XENOPORT INC
10% Owner
XERIS PHARMACEUTICALS INC
$ 12414862 The total value of shares held by James E Flynn
Insider Rank

James E Flynn ranks 2,277 out of 350,000 insiders. Go to Insider Ranking to see more.

Latest Insider Trading Transactions of James E Flynn

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases222883559
Value of Purchases ($)12,800,00012,800,00012,800,00034,105,00034,105,000143,880,000728,609,996
No. of Sales00007744
Value of Sales ($)00003,425,6233,425,62340,309,644

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   1 2 3 4 5 ... 10 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerOption ExerciseC0.0015,195,09400
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerBuyP16.00800,00012,800,0002,552,7871.8 M to 2.6 M (+45.64 %)
May 04 2021HOWLWerewolf Therapeut ...Flynn James E10% OwnerBuyC0.001,752,78701,752,7870 to 1.8 M
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.00433,55100
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.001,301,62600
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerOption ExerciseC0.001,572,96000
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerBuyP16.00625,00010,000,0003,933,1373.3 M to 3.9 M (+18.89 %)
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerBuyC0.00433,55103,308,1372.9 M to 3.3 M (+15.08 %)
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerBuyC0.001,301,62602,874,5861.6 M to 2.9 M (+82.75 %)
Mar 30 2021EWTXEdgewise Therapeut ...Flynn James E10% OwnerBuyC0.001,572,96001,572,9600 to 1.6 M
Feb 09 2021TERNTerns Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.001,717,03300
Feb 09 2021TERNTerns Pharmaceutic ...Flynn James E10% OwnerBuyP17.00665,00011,305,0002,382,0331.7 M to 2.4 M (+38.73 %)
Feb 09 2021TERNTerns Pharmaceutic ...Flynn James E10% OwnerBuyC0.001,717,03301,717,0330 to 1.7 M
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.24101,6002,259,797784,568886.2 K to 784.6 K (-11.47 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS23.573,91292,194886,168890.1 K to 886.2 K (-0.44 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS24.111,00024,108890,080891.1 K to 890.1 K (-0.11 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS25.054,378109,665891,080895.5 K to 891.1 K (-0.49 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS24.3511,794287,157895,458907.3 K to 895.5 K (-1.30 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.6493121,082907,252908.2 K to 907.3 K (-0.10 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.4728,108631,620908,183936.3 K to 908.2 K (-3.00 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.007,499,99900
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.007,499,99900
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00109,6121,644,180312,282202.7 K to 312.3 K (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00445,1946,677,9101,268,344823.2 K to 1.3 M (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00445,1946,677,9101,268,344823.2 K to 1.3 M (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700202,6700 to 202.7 K
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700823,150620.5 K to 823.2 K (+32.66 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700823,150620.5 K to 823.2 K (+32.66 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00620,4800620,4800 to 620.5 K
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00620,4800620,4800 to 620.5 K
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorOption ExerciseC0.001,002,46400
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorOption ExerciseC0.00189,36600
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorOption ExerciseC0.001,199,98000
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorOption ExerciseC0.00449,99200
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorOption ExerciseA18.0012,454224,17212,454
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyP18.00555,55610,000,0082,758,0002.2 M to 2.8 M (+25.22 %)
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyP18.00944,44416,999,9921,583,802639.4 K to 1.6 M (+147.72 %)
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyC0.001,002,46402,202,4441.2 M to 2.2 M (+83.54 %)
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyC0.00189,3660639,358450 K to 639.4 K (+42.08 %)
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyC0.001,199,98001,199,9800 to 1.2 M
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorBuyC0.00449,9920449,9920 to 450 K
Aug 12 2020AFIBAcutus Medical, In ...Flynn James EDirectorGrantA0.002,22202,2220 to 2.2 K
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerOption ExerciseC0.004,043,03100
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerOption ExerciseC0.004,043,03200
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerBuyP17.00350,0005,950,000808,914458.9 K to 808.9 K (+76.27 %)
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerBuyP17.00350,0005,950,000808,914458.9 K to 808.9 K (+76.27 %)
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerBuyC0.00458,9140458,9140 to 458.9 K
Jul 28 2020ANNXAnnexon, Inc.Flynn James E10% OwnerBuyC0.00458,9140458,9140 to 458.9 K
Jul 22 2020DFHTDeerfield Healthca ...Flynn James EDirectorBuyJ10.003,360,00033,600,0003,360,0000 to 3.4 M
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerOption ExerciseC0.002,626,76700
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerOption ExerciseC0.002,626,76700
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerBuyP18.00500,0009,000,0001,209,936709.9 K to 1.2 M (+70.43 %)
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerBuyP18.00500,0009,000,0001,209,936709.9 K to 1.2 M (+70.43 %)
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerBuyC0.00709,9360709,9360 to 709.9 K
Jul 14 2020NKTXNkarta, Inc.Flynn James E10% OwnerBuyC0.00709,9360709,9360 to 709.9 K
Jun 16 2020GBIOGeneration Bio Co.Flynn James E10% OwnerOption ExerciseC0.00455,50000
Jun 16 2020GBIOGeneration Bio Co.Flynn James E10% OwnerOption ExerciseC0.001,093,41000
Jun 16 2020GBIOGeneration Bio Co.Flynn James E10% OwnerBuyP19.00225,0004,275,0001,186,215961.2 K to 1.2 M (+23.41 %)
Jun 16 2020GBIOGeneration Bio Co.Flynn James E10% OwnerBuyC0.00257,8830961,215703.3 K to 961.2 K (+36.67 %)
Jun 16 2020GBIOGeneration Bio Co.Flynn James E10% OwnerBuyC0.00703,3320703,3320 to 703.3 K
Mar 17 2020DFPHDFP HEALTHCARE ACQ ...Flynn James EDirectorBuyJ10.002,500,00025,000,0002,500,0000 to 2.5 M
Mar 17 2020DFPHDFP HEALTHCARE ACQ ...Flynn James EDirectorBuyJ10.002,500,00025,000,0002,500,0000 to 2.5 M
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerOption ExerciseC0.00498,79500
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerOption ExerciseC0.00997,58900
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerBuyP17.00300,0005,100,000798,795498.8 K to 798.8 K (+60.14 %)
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerBuyP17.00300,0005,100,0001,297,589997.6 K to 1.3 M (+30.07 %)
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerBuyC0.00498,7950498,7950 to 498.8 K
Feb 18 2020RVMDRevolution Medicin ...Flynn James E10% OwnerBuyC0.00997,5890997,5890 to 997.6 K
Feb 10 2020SDGRSchrodinger, Inc.Flynn James E10% OwnerOption ExerciseC0.0010,063,06100
Feb 10 2020SDGRSchrodinger, Inc.Flynn James E10% OwnerBuyP17.00250,0004,250,000250,0000 to 250 K
Feb 10 2020SDGRSchrodinger, Inc.Flynn James E10% OwnerBuyC0.001,346,16701,346,1670 to 1.3 M
Feb 03 2020BDTXBlack Diamond Ther ...Flynn James E10% OwnerOption ExerciseC0.001,142,36100
Feb 03 2020BDTXBlack Diamond Ther ...Flynn James E10% OwnerBuyP19.00400,0007,600,000778,790378.8 K to 778.8 K (+105.60 %)
Feb 03 2020BDTXBlack Diamond Ther ...Flynn James E10% OwnerBuyC0.00378,7900378,7900 to 378.8 K
Jan 31 2020FIXXHomology Medicines ...Flynn James E10% OwnerSellS15.45509,9707,879,0370510 K to 0 (-100.00 %)
Jan 31 2020FIXXHomology Medicines ...Flynn James E10% OwnerSellS15.458,857136,808509,970518.8 K to 510 K (-1.71 %)
Jan 28 2020FIXXHomology Medicines ...Flynn James E10% OwnerSellS15.5165,8911,021,936518,827584.7 K to 518.8 K (-11.27 %)
Jan 28 2020FIXXHomology Medicines ...Flynn James E10% OwnerSellS15.77193,3593,049,600584,718778.1 K to 584.7 K (-24.85 %)
Jan 28 2020FIXXHomology Medicines ...Flynn James E10% OwnerSellS15.69380,2565,965,000778,0771.2 M to 778.1 K (-32.83 %)
Dec 27 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.95151,2333,319,5791,766,1061.9 M to 1.8 M (-7.89 %)
Dec 27 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.95198,7674,362,9562,321,1992.5 M to 2.3 M (-7.89 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.8356,5951,235,4351,917,3392 M to 1.9 M (-2.87 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.8374,3841,623,7582,519,9662.6 M to 2.5 M (-2.87 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.509,130196,2971,973,9342 M to 2 M (-0.46 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.5011,999257,9812,594,3502.6 M to 2.6 M (-0.46 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.685,454118,2191,983,0642 M to 2 M (-0.27 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.687,168155,3712,606,3492.6 M to 2.6 M (-0.27 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.8356,5951,235,4351,917,3392 M to 1.9 M (-2.87 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.8374,3841,623,7582,519,9662.6 M to 2.5 M (-2.87 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.509,130196,2971,973,9342 M to 2 M (-0.46 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.5011,999257,9812,594,3502.6 M to 2.6 M (-0.46 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.685,454118,2191,983,0642 M to 2 M (-0.27 %)
Dec 23 2019FIXXHomology Medicines ...Flynn James E10% OwnerSellS21.687,168155,3712,606,3492.6 M to 2.6 M (-0.27 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorOption ExerciseJ11.50460,6855,297,8781,640,981
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorOption ExerciseJ11.50460,6855,297,8781,640,981
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorSellJ0.006,087020,00026.1 K to 20 K (-23.33 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorSellJ0.006,087020,00026.1 K to 20 K (-23.33 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorSellJ0.00652,25302,279,8882.9 M to 2.3 M (-22.24 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorSellJ0.00652,25302,279,8882.9 M to 2.3 M (-22.24 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorGrantA10.0012,400,000124,000,00014,900,0002.5 M to 14.9 M (+496.00 %)
Nov 13 2019DFBHAdaptHealth Corp.Flynn James EDirectorGrantA10.0012,400,000124,000,00014,900,0002.5 M to 14.9 M (+496.00 %)
Oct 30 2019CABACabaletta Bio, Inc ...Flynn James E10% OwnerOption ExerciseC0.00696,37900
Oct 30 2019CABACabaletta Bio, Inc ...Flynn James E10% OwnerOption ExerciseC0.00696,37900
Oct 30 2019CABACabaletta Bio, Inc ...Flynn James E10% OwnerBuyP11.00700,0007,700,000700,0000 to 700 K
Oct 30 2019CABACabaletta Bio, Inc ...Flynn James E10% OwnerBuyC0.00464,2530464,2530 to 464.3 K
Oct 30 2019CABACabaletta Bio, Inc ...Flynn James E10% OwnerBuyC0.00464,2530464,2530 to 464.3 K
Oct 07 2019FREQFrequency Therapeu ...Flynn James E10% OwnerOption ExerciseC0.003,184,94800
Oct 07 2019FREQFrequency Therapeu ...Flynn James E10% OwnerOption ExerciseC0.003,184,94800
Oct 07 2019FREQFrequency Therapeu ...Flynn James E10% OwnerBuyP14.00285,7143,999,996285,7140 to 285.7 K
Oct 07 2019FREQFrequency Therapeu ...Flynn James E10% OwnerBuyC0.00472,8600472,8600 to 472.9 K
Oct 07 2019FREQFrequency Therapeu ...Flynn James E10% OwnerBuyC0.00472,8600472,8600 to 472.9 K
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.0012,467,65000
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.0012,467,65000
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerBuyP15.00166,0002,490,000166,0000 to 166 K
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerBuyP15.00166,0002,490,0001,724,4561.6 M to 1.7 M (+10.65 %)
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerBuyC0.001,558,45601,558,4560 to 1.6 M
Jul 24 2019MIRMMirum Pharmaceutic ...Flynn James E10% OwnerBuyC0.001,558,45601,558,4560 to 1.6 M
Jul 01 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS2.69590,8011,589,6683,159,1653.7 M to 3.2 M (-15.75 %)
Jul 01 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS2.69108,674292,409964,1011.1 M to 964.1 K (-10.13 %)
Jun 26 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.501,3526,0863,749,9663.8 M to 3.7 M (-0.04 %)
Jun 26 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.503521,5851,072,7751.1 M to 1.1 M (-0.03 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5140,850184,1893,751,3183.8 M to 3.8 M (-1.08 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5110,63447,9481,073,1271.1 M to 1.1 M (-0.98 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5250,177226,9253,792,1683.8 M to 3.8 M (-1.31 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5213,06359,0771,083,7611.1 M to 1.1 M (-1.19 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.62269,4021,243,3983,842,3454.1 M to 3.8 M (-6.55 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.6270,135323,7011,096,8241.2 M to 1.1 M (-6.01 %)
Jun 11 2019FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseA19.5115,580303,96615,580
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.0571,869434,7501,166,9591.2 M to 1.2 M (-5.80 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.05108,696657,5244,111,7474.2 M to 4.1 M (-2.58 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.16172,8001,064,0161,238,8281.4 M to 1.2 M (-12.24 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.16261,3451,609,2324,220,4434.5 M to 4.2 M (-5.83 %)
Apr 15 2019FIXXHomology Medicines ...Flynn James EDirectorBuyP22.50533,33311,999,9931,158,333625 K to 1.2 M (+85.33 %)
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerOption ExerciseC0.00284,65900
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerOption ExerciseC0.001,619,43300
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerOption ExerciseC0.00284,65900
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerOption ExerciseC0.001,619,43300
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyP17.0010,000170,00010,0000 to 10 K
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyP17.0010,000170,000166,073156.1 K to 166.1 K (+6.41 %)
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyP17.0010,000170,000166,073156.1 K to 166.1 K (+6.41 %)
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyC0.0023,3330156,073132.7 K to 156.1 K (+17.58 %)
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyC0.00132,7400132,7400 to 132.7 K
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyC0.0023,3330156,073132.7 K to 156.1 K (+17.58 %)
Mar 11 2019SWAVShockWave Medical, ...Flynn James E10% OwnerBuyC0.00132,7400132,7400 to 132.7 K
Feb 12 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.001,35120,265856,470857.8 K to 856.5 K (-0.16 %)
Feb 12 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.115,89088,986857,821863.7 K to 857.8 K (-0.68 %)
Feb 07 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.009,409141,135863,711873.1 K to 863.7 K (-1.08 %)

Page:   1 2 3 4 5 ... 10 next >